AAT Form 144: Proposed resale of RSU-derived shares
AAT submitted a Form 144 notice indicating proposed sales of Common Stock by the issuer under equity compensation awards.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
AAT submitted a Form 144 notice indicating proposed sales of Common Stock by the issuer under equity compensation awards. The notice lists restricted stock unit grants dated 06/08/2021 (1,296 shares), 06/07/2022 (1,518 shares), 06/05/2023 (2,587 shares), 06/03/2024 (2,295 shares), and 06/02/2025 (4,453 shares).
The form records brokerage details referencing Charles Schwab & Co., Inc. and shows an execution date field of 06/24/2026. The filing is a routine insider resale notice for RSU-derived shares; cash-flow treatment and final sale amounts are not detailed here.
Insights
Routine Form 144 lists proposed resale of RSU-derived common shares across multiple grant dates.
The filing enumerates RSU grant dates and share counts: 06/08/2021 (1,296), 06/07/2022 (1,518), 06/05/2023 (2,587), 06/03/2024 (2,295), and 06/02/2025 (4,453). These are presented as equity compensation sources.
Timing and cash‑flow treatment for any completed sales are not included in the excerpt; subsequent transaction confirmations or broker reports would show execution details.
Key Figures
Key Terms
Form 144 regulatory
RSU Stock Grants financial
Restricted Stock Units financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does AAT's Form 144 disclose about insider sales?
Does the Form 144 show completed sales for AAT?
Who is handling the transactions listed on AAT's Form 144?
AI-generated analysis. How Rhea-AI works. Not financial advice.